Brett Giroir | |
---|---|
16th Assistant Secretary for Health | |
In office February 15, 2018 –January 19, 2021 | |
President | Donald Trump |
Secretary | Alex Azar |
Preceded by | Howard Koh |
Succeeded by | Rachel Levine |
Commissioner of Food and Drugs | |
Acting November 6,2019 –December 17,2019 | |
President | Donald Trump |
Preceded by | Norman Sharpless (acting) |
Succeeded by | Stephen Hahn |
Personal details | |
Born | Marrero,Louisiana,U.S. | November 4,1960
Education | Harvard University (BA) University of Texas Southwestern (MD) |
Signature | |
Uniformed service | |
Allegiance | United States |
Service/ | United States Public Health Service Commissioned Corps |
Years of service | 2018–2021 |
Rank | Admiral |
Brett P. Giroir (pronounced jir-WAH) (born November 4,1960) [1] is an American pediatrician. He was formerly the U.S. assistant secretary for health,a four-star admiral in the U.S. Public Health Service Commissioned Corps and an acting Food and Drug Administration commissioner.
From 2004 to 2008,Giroir served as the deputy director,and then a director,of DARPA's Defense Science Office,vice chancellor for the Texas A&M University System from 2008 to 2013,and as the chief executive officer of the Texas A&M Health Science Center from 2013 to 2015. [2]
Giroir starting in 2016 served as president and CEO of ViraCyte,LLC,a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe infections. He also served as a senior fellow at the Texas Medical Center Health Policy Institute and strategic advisor for the Texas Medical Center Innovation Institute (TMCII). He was a member of the Texas Task Force for Infectious Disease Preparedness and Response,and an adjunct professor of pediatrics at the Baylor College of Medicine in Houston. [3]
Giroir served as the Acting Commissioner of Food and Drugs in November and December 2019,while Stephen Hahn's nomination was pending in the Senate.
Giroir graduated from all-male Catholic Jesuit High School in New Orleans,Louisiana, [4] where he was also served as a drill team commander in the U.S. Marine Corps JROTC. [5] He received his A.B. degree in biology from Harvard University,magna cum laude,in 1982. [6] [7] He was the first to attend college in his family. [8] Giroir earned his M.D. from the University of Texas Southwestern Medical Center (UTSW) in Dallas,Texas, [6] [9] in 1986,inducted into the Alpha Omega Alpha honor society,and served his residency (1986–1989),chief residency (1989–1990) and fellowship (1990–1991) in pediatrics at the medical center,at Children's Medical Center Dallas and Parkland Memorial Hospital. [10] Giroir received his post-doctoral training at the Howard Hughes Medical Institute in Dallas,from 1991 to 1993. [11] [12]
Following his fellowship,Giroir served on the faculty at UTSW (1993–2004), [13] becoming a tenured professor. He was the inaugural holder of the Associates First Capital Corporation Distinguished Chair in Pediatrics, [14] and the Kathryne and Gene Bishop Distinguished Chair in Pediatric Care. [15] His administrative positions included director of the Division of Pediatric Critical Care Medicine [16] and director of the pediatric intensive care units at Children's Medical Center and Parkland. In 2000,Giroir was named the associate dean for Clinical Affairs at UTSW,while taking on the role as the inaugural chief medical officer at Children's Medical Center Dallas. Giroir led a medical staff of over 750 physicians. His research focused on severe life-threatening infectious diseases,including meningococcal disease ("the college meningitis"). Giroir's research was featured on a PBS NOVA entitled "Killer Disease on Campus" [17] which originally aired in 2002. Giroir has published over 85 academic articles,chapters,and books on a variety of topics including host-pathogen interactions and novel therapies for life-threatening infectious diseases. [18]
While continuing to serve full-time at UTSW,Giroir was a member of the Defense Sciences Research Council (DSRC,1999–2004),an academic and technical assessment council charged with assisting DARPA (the Defense Advanced Research Projects Agency) in developing novel,world-changing R&D initiatives. Giroir co-chaired or participated in studies related to biological weapons decontamination and universal medial countermeasures to biological threats during his appointment with the DSRC. [19]
In 2004,Giroir accepted a full-time position at DARPA as deputy director of the Defense Sciences Office (DSO),and then as its director from 2007 to 2008. Among the programs begun during this time were a biodefense thrust known as Accelerating Critical Therapeutics and programs in fundamental mathematics,engineering,and human performance. During Giroir's tenure,the DSO developed various biodefense programs and other programs related to biosecurity with the goal of developing new technologies and approaches to be transitioned for translation by other agencies. [19]
Giroir was also selected as a member of the Defense Sciences Study Group, [20] a two-year program to develop emerging leaders in science and technology. He was a member of the external advisory board,NASA National Center for Space Biological Technologies (2003–2007),and the chair on the Chemical and Biological Defense Panel (2009–2010) for the Threat Reduction Advisory Committee (TRAC). [19]
Giroir served as vice chancellor for research (2008–2011),vice chancellor for strategic initiatives (2011–2013),and executive vice president and CEO of the Texas A&M Health Science Center (2013–2015). He held professor appointments in the Texas A&M College of Medicine and the Dwight Look College of Engineering,and an adjunct professor appointment at The Bush School of Government and Public Service. Giroir's focus was leading the development of the biotechnology initiatives within the Texas A&M University System and the Biocorridor in Brazos County. [21] In this regard,Giroir was the lead investigator and program director for the design,development,and implementation of the National Center for Therapeutics Manufacturing (NCTM),a biopharmaceutical research and development program at Texas A&M University. [22]
Giroir from 2014 to 2015 chaired the independent Blue Ribbon Panel for the Veterans Choice Act,whose assessment and recommendations to reform the Veterans Administration Health System were delivered to Congress and Secretary Robert McDonald in September 2015. He testified to the House Committee on Veterans Affairs the following month and communicated priorities for VA reform. [23]
Giroir was told on June 1,2015,that he had 30 minutes to resign or he would be fired. [24] [2] [25] [26] Giroir chose to resign,after eight years of work on several vaccine projects. [2] [25] [26] The notification stated that he had to leave the building immediately,and would no longer have access to his email. [2] His annual performance evaluation at Texas A&M said that he was "more interested in promoting yourself" than the health science center where he worked. He got low marks on being a "team player." [27] [28] [29] [30] Robin Robinson,who was the director of the federal Biomedical Advanced Research and Development Authority and oversaw a major grant for the Texas vaccine project,said Giroir "over-promised and under-delivered." [31] Texas A&M Health Science Center doubled its NIH funding during Giroir's tenure,though the university stated that most of the credit for that was not the function of the work of Giroir,but rather of others,and there was concern that plans to build a teaching hospital on the College Station campus never materialized. [2]
After resigning from Texas A&M,Giroir founded sole proprietorship Health Science and Biosecurity Partners, [3] [32] a consulting firm focused on life science innovation,strategy,and investments. [33]
Starting in November 2016,Giroir served as president and CEO of ViraCyte,LLC,a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe infections. [34]
President Donald Trump nominated Giroir for appointment as a commissioned officer,and appointment to the rank of admiral in the U.S. Public Health Service Commissioned Corps,while serving as the assistant secretary for health,on May 25,2017. [35] In August 2017,the Senate committee on Health,Education,Labor and Pensions held up Giroir's confirmation, [36] due to skepticism over his testimony that he would support women's health programs. [36] [37] The Senate returned his nomination back to the President on January 3,2018,without action. [35] He was renominated on January 8,2018, [38] and confirmed via voice vote on February 7,2018. [37] [38]
Giroir received his commission and four-star rank in the commissioned corps,a week after he assumed the office of assistant secretary on February 15,2018. [39] [40] [41] He was also appointed by the secretary to the additional role as mental health senior adviser on March 29,2018. [42]
In April 2018,Senator Ron Wyden (D-Oregon) criticized Giroir for neglecting to address the role of drug companies in sparking the opioid crisis. [43] In September 2018,Senator Claire McCaskill (D-Missouri) wrote to Health Secretary Alex Azar:"At a hearing of the Senate Committee on Finance in April 2018,I asked Admiral Brett P. Giroir ... whether HHS had demanded explanations from pharmaceutical manufacturers that had raised prices for the opioid-reversal drug naloxone. Admiral Giroir stated he had not asked the companies to explain their dramatic price increases,but promised he would 'get back to [me] on whether [he] could write a letter.' I am not aware,however,of outreach from HHS to my office on this issue." [44]
In November 2018,Giroir wrote a letter in which he said that the agency was seeking to end the use of fetal tissue in taxpayer-funded biomedical research involving developing vaccines and researching the Zika virus,and treatments for Alzheimer's disease and Parkinson's,if it can find "adequate alternatives",and said the HHS was "pro-life and pro-science". [45] The National Institutes of Health at the time funded more than $100 million in research drawing on fetal tissue. [45]
In May 2020,Senator Mitt Romney (R-Utah) criticized Giroir at a Senate health committee hearing for his participation in a White House event celebrating that the U.S. had conducted more coronavirus tests than South Korea. [46] Romney said the difference was that South Korea tested early,and the U.S. was catching up—which could result in many more American deaths. [46] Romney said:"I understand that politicians are going to frame data in a way that is most positive politically. Of course,I don't expect that from admirals. But you ignored the fact that they accomplished theirs at the beginning of the outbreak,while we treaded water during February and March.... The fact is their test numbers are going down,down,down now,because they don't have the kind of outbreak we have. Ours are going up,up,up...." [46] [47]
On November 1,2019,HHS Secretary Alex Azar announced that Giroir would serve as Acting Commissioner of Food and Drugs until Stephen Hahn,whose nomination for the same position was announced on the same day,was confirmed by the U.S. Senate. [48] [49] [50] Senator Patty Murray (D-Washington) said that she was "alarmed" by Giroir's "track record of letting ideology drive decisions at the expense of women and families." [51] Giroir served as Acting Commissioner in November and December 2019,while Hahn's nomination was pending in the Senate. [52] [53]
On November 15,2018,President Trump nominated Giroir to serve the additional role of representative of the United States on the executive board of the World Health Organization. [54] [55] The nomination was returned to the President on January 3,2019,without action by the Senate. [55] He was renominated on January 16,2019, [56] but that nomination was also returned to the President on January 3,2020,without action. [56] He was renominated for a third time on March 18,2020. [57] Giroir was finally confirmed by the Senate in a voice vote on May 7,2020. [57] He served on the executive board,for the remainder of the current three-year term cycle,which expired in January 2021. [58]
Giroir resigned from his government positions on January 19,2021,as expected from all appointed government leadership,in order to facilitate a smooth transition to the new Biden administration. [59] [60]
Giroir served on the scientific advisory boards of the Cancer Moonshots Program at MD Anderson Cancer Center,the A. Alfred Taubman Medical Research Institute at the University of Michigan,the Institute for Patient Safety at the University of North Texas Health Science Center,and was a member of the board of directors of Esperance Pharmaceuticals [61] and BioHouston. [62]
He appeared before the House Armed Services Committee Subcommittee on Intelligence,Emerging Threats and Capabilities hearing on Biodefense:Worldwide Threats and Countermeasure Efforts for the Department of Defense in October 2013. [63]
On October 6,2014,Governor Rick Perry announced the creation of the Texas Task Force on Infectious Disease Preparedness and Response to assess and enhance the state's existing capabilities to prepare for and respond to pandemic diseases such as the Ebola virus. The Governor named Giroir as director of the task force to lead a team of experts in epidemiology and infectious disease. [64]
Giroir is the recipient of the following awards and decorations: [65]
The United States Department of Health and Human Services (HHS) is a cabinet-level executive branch department of the U.S. federal government created to protect the health of the U.S. people and providing essential human services. Its motto is "Improving the health, safety, and well-being of America". Before the separate federal Department of Education was created in 1979, it was called the Department of Health, Education, and Welfare (HEW).
The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.
The Presidential Advisory Council on HIV/AIDS (PACHA) advises the White House and the Secretary of Health and Human Services on the US government's response to the AIDS epidemic. The commission was formed by President Bill Clinton in 1995 and each president since has renewed the council's charter.
Alex Michael Azar II is an American attorney, businessman, lobbyist, and former pharmaceutical executive who served as the U.S. Secretary of Health and Human Services from 2018 to 2021. Azar was nominated to his post by President Donald Trump on November 13, 2017, and confirmed by the United States Senate on January 24, 2018. He was also chairman of the White House Coronavirus Task Force from its inception in January 2020 to February 2020, when he was replaced by Vice President Mike Pence.
Stephen Michael Hahn is an American physician who served as the commissioner of food and drugs from 2019 to 2021. Before becoming commissioner, he was an oncologist serving as chief medical executive of the MD Anderson Cancer Center. In 2021, he became chief medical officer at Flagship Pioneering, the venture capital firm that launched Moderna.
The United States commissioner of food and drugs is the head of the Food and Drug Administration (FDA), an agency of the United States Department of Health and Human Services. The commissioner is appointed by the president of the United States and must be confirmed by the Senate. The commissioner reports to the secretary of health and human services.
The Biomedical Advanced Research and Development Authority (BARDA)' is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.
Daniel Ronald Levinson is an American attorney who served as Inspector General for the U.S. Department of Health and Human Services (HHS) from September 8, 2004, to May 31, 2019. HHS is among the largest departments in the federal government, encompassing Medicare, Medicaid, public health, medical research, food and drug safety, welfare, child and family services, disease prevention, Indian health, and mental health services. It also exercises leadership responsibilities in public health emergency preparedness and combating bio-terrorism.
Mark Edward Green is an American politician, physician, and retired U.S. Army major who has served as the U.S. representative for Tennessee's 7th congressional district since 2019. A member of the Republican Party, Green has chaired the Committee on Homeland Security since 2023. Before his election to Congress, he served in the Tennessee Senate from 2013 to 2018, representing the 22nd district.
Karen Bollinger DeSalvo is an American business executive, physician and public health expert. She has been Google’s chief health officer since 2019. Previously, she served as the Acting Assistant Secretary for Health, National Coordinator for Health Information Technology, and Director of the Office of the National Coordinator for Health Information Technology (ONC).
Jerome Michael Adams is an American anesthesiologist and a former vice admiral in the U.S. Public Health Service Commissioned Corps who served as the 20th surgeon general of the United States from September 5, 2017, until January 20, 2021. Prior to becoming Surgeon General, he served as the Indiana state health commissioner, from 2014 to 2017.
Donald Trump assumed office as president of the United States on January 20, 2017, and his term ended on January 20, 2021. The president has the authority to nominate members of his Cabinet to the United States Senate for confirmation under the Appointments Clause of the United States Constitution.
Elinore F. McCance-Katz is an American physician, academic, and government official who served as Assistant Secretary of Health and Human Services for Mental Health and Substance Use from 2017 to 2021. Prior to assuming her current role, she was the chief medical officer for the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities, and Hospitals and a professor at the Alpert Medical School at Brown University. Her nomination was supported by the American Psychiatric Association, which released a statement saying "Dr. McCance-Katz has a wealth of experience in academic and public sector settings in addressing mental health and substance use disorders."
Robert Peter Kadlec is an American physician and career officer in the United States Air Force who served as Assistant Secretary of Health and Human Services from August 2017 until January 2021. He is responsible for the creation of the COVID-19 vaccine development program Operation Warp Speed.
Donald John Wright is an American physician, government official, and diplomat who served as United States Ambassador to Tanzania between 2020 and 2023.
Ronny Lynn Jackson is an American physician, politician, and former United States Navy officer. He is the U.S. representative for Texas's 13th congressional district.
The White House Coronavirus Task Force was the United States Department of State task force during the Trump administration, the goal of the Task Force was to coordinate and oversee the administration's efforts to monitor, prevent, contain, and mitigate the spread of coronavirus disease 2019 (COVID-19). Also referred to as the President's Coronavirus Task Force, it was established on January 29, 2020, with Secretary of Health and Human Services Alex Azar as chair. On February 26, 2020, U.S. vice president Mike Pence was named to chair the task force, and Deborah Birx was named the response coordinator.
Rachel Leland Levine is an American pediatrician who has served as the United States assistant secretary for health since March 26, 2021. She is also an admiral in the United States Public Health Service Commissioned Corps.
Brian Edward Harrison is an American government official who served as chief of staff of the United States Department of Health and Human Services (HHS). He ran for the United States House of Representatives in the 2021 special election for Texas's 6th congressional district, gaining 10.8% of the vote and placing fourth in a field of 23 candidates. He won the special election race for the Texas House of Representatives District 10 on September 28, 2021.
{{cite book}}
: CS1 maint: multiple names: authors list (link){{cite book}}
: CS1 maint: multiple names: authors list (link){{cite web}}
: CS1 maint: multiple names: authors list (link)